Form 4: Marimed CEO Jon Levine Reports Stock Sale and RSU Vesting
SEC Form 4 Filing
Marimed Inc. CEO Jon Levine reported the vesting of restricted stock units (RSUs) and the subsequent sale of shares to cover tax obligations.
Summary
- On March 7, 2024, Jon Levine, the President and CEO of Marimed Inc., reported transactions involving the company's common stock.
- 46,667 Restricted Stock Units (RSUs) vested, converting into common stock on a one-for-one basis.
- Levine sold 16,529 shares of common stock at a price of $0.2348 per share.
- The sale was executed under a pre-existing Rule 10b5-1 trading plan adopted on March 10, 2023, to cover tax withholding obligations related to the RSU vesting.
- Following these transactions, Levine directly owns 20,229,020 shares of common stock and indirectly owns 6,684,640 shares through the Jon Levine Family Trust.
- An additional 23,333 RSUs will vest every six months through March 7, 2026.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing primarily reports routine transactions related to executive compensation and tax obligations. There is no indication of positive or negative implications for the company's performance.
Future Outlook
Future vesting of 23,333 RSUs every six months until March 7, 2026.
Industry Context
This filing is a routine disclosure related to executive compensation and stock transactions, common in publicly traded companies. It provides transparency regarding the insider's holdings and trading activities.
Key Dates
| Date | Description |
|---|---|
| 03/10/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 03/07/2024 | Date of RSU vesting and stock sale |
| 03/07/2026 | Final vesting date for remaining RSUs |
| 03/08/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.